Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 22, 2018

DrugPatentWatch Database Preview

Chartwell Rx Company Profile

« Back to Dashboard

What is the competitive landscape for CHARTWELL RX, and what generic and branded alternatives to CHARTWELL RX drugs are available?

CHARTWELL RX has forty-seven approved drugs.

Summary for Chartwell Rx

US Patents:	0
Tradenames:	25
Ingredients:	22
NDAs:	47

Drugs and US Patents for Chartwell Rx

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Rx	HYDRALAZINE HYDROCHLORIDE	hydralazine hydrochloride	TABLET;ORAL	088847-001	Feb 26, 1985		DISCN	No	No		➤ Sign Up				➤ Sign Up
Chartwell Rx	FULVICIN-U/F	griseofulvin, microcrystalline	TABLET;ORAL	060569-002	Approved Prior to Jan 1, 1982		DISCN	No	No		➤ Sign Up				➤ Sign Up
Chartwell Rx	CILOSTAZOL	cilostazol	TABLET;ORAL	077722-001	Sep 24, 2012	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Chartwell Rx	PHENTERMINE HYDROCHLORIDE	phentermine hydrochloride	CAPSULE;ORAL	088625-001	Aug 23, 1984		DISCN	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji

Federal Trade Commission

UBS

AstraZeneca

Express Scripts

Accenture

Cantor Fitzgerald

Baxter

Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.